Industries > Pharma > Medical Device Contract Manufacturing: World Market Outlook 2013-2023

Medical Device Contract Manufacturing: World Market Outlook 2013-2023

PUBLISHED: 23 January 2013
PAGES: 125

WOOCS 2.2.1
SKU: N/A Categories: , ,

The medical device contract manufacturing market will witness significant growth during 2013-2023, driven by an expanding medical devices market. According to Visiongain estimates, the global medical devices market was worth $266.0bn in 2011. In the past, the medical device industry maintained a low level of outsourcing due to concerns over quality, delays and regulatory compliance. In recent years however, outsourcing has become more attractive, driven by the Original Equipment Manufacturers (OEMs) need to reduce costs and to accelerate the time to market. Contract manufacturers themselves have started to diversify their capabilities over the years and are able to offer a range of services, including design, engineering, packaging and distribution. The medical device contract manufacturing market was worth $33.6bn in 2011. It is estimated that outsourcing has allowed OEMs to reduce costs by 10-30%. More outsourcing companies are adopting the one stop-shop model to provide the entire range of outsourcing activities to OEMs. Overall, outsourcing allows OEMs to focus on their core competencies while delegating other non core activities to contract manufacturers.

In 2011, the US was the largest national market for contract manufacturing, accounting for 47.3% of the global market. However, Asian countries, particularly China and India are proving to be attractive low cost destinations for OEMs, witnessing a stronger growth rate compared to other developed countries. Additionally, with increasing cost pressures on OEMs which may intensify with the impending medical device excise tax, the offshoring of manufacturing to the CMOs based in low-cost destinations will become a strategic necessity. At present, the contract manufacturing market is highly fragmented with thousands of companies competing for a small share of the market. However, this may change significantly in the future with major consolidations within the industry.

Visiongain's updated report on Medical Device Contract Manufacturing 2013-2023 examines the medical devices and contract manufacturing market with respect to market size and sales forecasts from 2013-2023. It also discusses the detailed market forecasts for three main segments of contract manufacturing including material processing, electronics and finished products. The report discusses the estimates and projections for major geographical markets including the US, Germany, France, Italy, UK, Spain, Japan, China and India from 2013-2023. The various drivers and restraints of the market are evaluated in order to provide readers with specific insights into the future direction of the industry, while the analysis is underpinned by original interview with an expert within the medical device contract manufacturing market.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national markets forecasts from 2012-2023 – all highlighting key business opportunities.

Why you should buy Medical Device Contract Manufacturing: World Market Outlook 2013-2023

• 123 pages of comprehensive analysis
• 1 Exclusive Visiongain interview with experts from:
– Creganna-Tactx Medical
• 72 tables, charts, and graphs
• Medical device contract manufacturing market forecast between 2012-2023
• 3 medical device contract manufacturing submarket forecasts from 2012-2023
– Material Processing
– Electronic Manufacturing Services
– Finished Products
• A SWOT analysis
• Several leading companies identified and 6 profiled:
Accellent, Flextronics, Symmetry Medical, The Tech Group, Greatbach, Nortech Systems

You can order this report today

Gain an understanding of the overall medical device contract manufacturing market and the leading companies operating in this market by ordering Medical Device Contract Manufacturing: World Market Outlook 2013-2023.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6 

To view free sample pages of this report please click here

Download sample pages

Complete the form below to download your free sample pages for Medical Device Contract Manufacturing: World Market Outlook 2013-2023

Download sample pages

Complete the form below to download your free sample pages for Medical Device Contract Manufacturing: World Market Outlook 2013-2023

Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021


Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021


Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021


Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021